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Abstract
Background: Cerebrovascular disease is the second commonest cause of death, and over a third of stroke deaths
occur in developing countries. To fulfil the current gap on data, this systematic review is focused on the frequency
of stroke, risk factors, stroke types and mortality in Iran.
Methods: Thirteen relevant articles were identified by keyword searching of PubMed, Iranmedex, Iranian University
index Libraries and the official national data on burden of diseases.
Results: The publication dates ranged from 1990 to 2008. The annual stroke incidence of various ages ranged
from 23 to 103 per 100,000 population. This is comparable to the figures from Arab Countries, higher than sub-
Saharan Africa, but lower than developed countries, India, the Caribbean, Latin America, and China. Similarly to
other countries, ischaemic stroke was the commonest subtype. Likewise, the most common related risk factor is
hypertension in adults, but cardiac causes in young stroke. The 28-day case fatality rate is reported at 19-31%.
Conclusions: Data on the epidemiology of stroke, its pattern and risk factors from Iran is scarce, but the available
data highlights relatively low incidence of stroke. This may reflect a similarity towards the neighbouring nations,
and a contrast with the West.
Background
Iran, known as Persia until 1935, is located in Southwest
Asia (figure 1). With an area of 1,648,000 square kilo-
meters, Iran ranks sixteenth in size among the countries
of the world and its climate ranges from subtropical to
subpolar [1]. Its has a population of 70 million, with
more than 13 millions living in the capital Tehran [2].
One quarter of its people are 15 years of age or younger,
compared with 7.26% of the population aged 60 or over
[2]. Iran with its Indo-European origin and historically
being a major crossroad for human migration is a coun-
try composed of different ethnic groups including Per-
sian (51%), Azeri (24%), Gilaki and Mazandarani (8%),
Kurd (7%), Arab (3%) as well as, Baluch, Turkman, Jews,
Armenians, Assyrians and Zoarastians [1].
Over the last couple of decades, there has been major
improvement in education and health services. The
number of universities has grown from 22 in 1978 to 54
state universities and 289 major private universities in
2009 [3]. The Iranian Medical Council reports over
100,000 physicians, including 660 neurologists, practis-
ing in the year 2009 [4]. However, about 150 neurolo-
gists are based in Tehran with over 40 MRI scanning
centres, at least double than the necessary epuipment
for the population [5]. According to the World Health
Organisation (WHO), life expectancy at birth in Iran is
estimated at 69 years for male and 73 years for female
in 2006 [6]. The total expenditure on health in 2005 is
covered by the government and the private sector at
55.8% and 44.2%, respectively [6].
Cerebrovascular disease is the second commonest
cause of death, and the 6
th leading cause of diseases
burden globally and expected to move to the 4
th place
by 2020 [7]. Over 80% of all stroke deaths in the world
occur in the developing countries [8]. However, stroke
is largely preventable, so knowledge of risk factors
within a certain country is an essential step in reducing
the stroke rate and resulting disease burden. Also, life-
style and vascular risk factors such as hypertension and
diabetes vary among different countries and cultures.
An examination of stroke frequency and clinical pattern
in various nations is therefore important to understand
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the ultimate aim of reducing the stroke rate. Effective
prevention programmes should also be based on data
relevant to the country under study. The literature
representing the burden of stroke in developing coun-
tries and Asia is lacking comprehensive data on Iran.
Epidemiological studies of stroke in these countries are
constantly bound to numerous limitations such as
inadequate nationwide data sets, lack of standard popu-
lation-based studies, flawed medical registration and dis-
continuity of data maintenance between the family
physicians, state healthcare system as well as private sec-
tor. Furthermore, those published, can remain inaccessi-
ble when written in the local or national Persian
journals. The aim of this paper is to systematically
review the data related to the frequency, risk factors,
types and mortality of stroke in Iran. This should iden-
tify future potential research areas and help in medical
service planning in the Iran. To our knowledge, no pre-
vious systematic reviews of stroke in Iran have been
undertaken.
Methods
Data collection
The data was collected over four stages: -
Stage 1 - search through PubMed
Publications on Stroke in Iran were identified by search-
ing the PubMed using the keywords:- “stroke”, “intra-
cranial bleed”, “intracranial haemorrhage”, “brain
infarction”, “cerebrovascular disorders”, “cerebrovascular
disease”, “epidemiology”, “incidence”, “prevalence” com-
bined with “Iran”, “Iranian”, “Persian”, “Persia” and
“Farsi”.
Titles and abstracts were scanned by one author (AH)
to identify eligible studies according to agreed inclusion
and exclusion criteria. The full paper of potential studies
was retrieved for more detailed assessment.
Stage 2 - search through “Iranmedex” and Iranian
University Index Libraries
IranMedex is the website for Iranian medical index
database (http://www.iranmedex.com). The website is a
search engine to identify studies published in Persian or
English, including articles in Persian or International
journals, medical thesis or scientific reports. IranMedex
enables one to purchase some articles or abstracts but
not all.
The above mentioned keywords were used to identify
articles by searching Iranmedex for further articles. The
titles of all related articles and medical theses were
reviewed. Since the full papers of many studies were not
Figure 1 Map of Iran.
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(DSR) searched medical index for each major medical
school in Iran, and the well-known Iranian medical jour-
nals to get hold of the relevant papers. To access the
medical theses, medical index libraries were visited to
copy or scan the relevant parts and forward it to the
co-author (AH).
Stage 3 - search the references of the relevant papers
Each reference in all relevant papers was checked for
any additional articles.
Stage 4 - Official Data on “Burden of Disease in Iran”
The data for the year 2003 is published in a book
“National Burden of Disease & Injury in Iran”, so-called
“The Green Book”, with exclusive rights to the Ministry
of Health. It reports the results of the study on the
national burden of disease. The ongoing project is
implemented by the Ministry of Health and Medical
Education including a team of epidemiologists, sociolo-
gists, medical and dental specialists. The study is con-
ducted in 6 provinces including: Eastern Azarbayejan,
Booshehr, Chahar Mahal & Bakhtiari, Khorasan, Hor-
mozgan and Yazd. A software coding system, which is
comparable with global burden of disease studies, is
designed for the study to collect the data from both hos-
pitals and primary health care systems.
The access to the official data was obtained via direct
communication with the current Ministry of Health in
Iran. Although the data has valuable information on the
nationwide burden of diseases, it does not carry strong
pathophysiological and epidemiological value [9]. The
reported incidence and mortality statistics are limited by
inaccuracy, variable diagnostic and coding methods by
both medical and non-medical administrative staff, and
the absence access to detailed information on the cases,
pathology subtypes, methods and individual studies. We
therefore, did not include the data in this study.
Inclusion and exclusion criteria
Papers were selected for this systematic review if they
fulfilled the following criteria:
1. The study was conducted in Iran,
2. The stroke is clearly defined, the definition varied
in different studies: mostly defined as a focal neuro-
logical deficit, confirmed by a trained physician, that
persisted for at least 24 hours; all the cases recruited
to the study had brain computed tomography (CT)
or magnetic resonance imaging (MRI) and under-
went batteries of standard investigations including at
least electrocardiography, blood count, serum elec-
trolytes, blood sugar and lipid profile.
3. The study contained data about frequency (inci-
dence, prevalence) or clinical pattern (types, risk fac-
tors and outcome) or mortality rate of stroke,
4. The study was published before 2
nd February
2009, and written in English or Persian,
5. Studies on cerebral venous sinus thrombosis and
comparative studies on individual stroke risk factor
analysis were excluded.
Data extraction
The following data were extracted from identified
papers: stroke incidence, prevalence, patient sex and
age, stroke type, risk factors, and clinical outcome. The
included articles were reviewed and data was analysed
descriptively. Statistical analysis or meta-analysis was
not attempted due to significant variability in both data
sources and study methodologies.
Results
The data selection process is shown in figure 2. The
details of all the stroke studies in Iran, both included and
excluded from this study, are tabulated in table 1. Thir-
teen articles, which fulfilled the inclusion and exclusion
criteria, are included in this systematic review [10-22].
Incidence
There is only one study showing an incidence of 43.12/
100,000 population/year of first-ever ischaemic stroke in
all age range in Iran [17]. Whilst a study showed an
annual incidence rate of 22.7 per 100,000 population for
first ever and recurrent stroke, another reported a rising
incidence from 84.16 to 103.23/100,000 population over
four years [10,20]. Ischaemic stroke events made up the
majority in both the studies at 67% to 68% of the cases
[10,20]. The annual incidence of young stroke (age 25-
45) was 8 and 1.83/100,000 population for children
below age of 15 [12,15]. Non-traumatic brain haemor-
rhage was reported at 15.5 per 100,000 per year [23].
Summary of all incidence studies is shown in table 2.
Sex and Age
S t r o k ew a sr e p o r t e dt ob es l i g h t l ym o r ec o m m o ni n
females (range form 51%-53%) in the studies that included
all age range [10,17,20]. However, stroke was more com-
mon in young males, age between 15-45, (52%) [15] and in
boys (59%) [12]. The clinical series showed a mean age of
stroke within the 7
th decade [10,17,20]. However, haemor-
rhagic stroke was reported more commonly in women
(57.9% for intracranial haemorrhage) [21,24].
Types of stroke
Only two studies reported all types of strokes [10,20].
Ischaemic stroke was reported in 67.2-68.45% of all
stroke patients while primary intracerebral haemorrhage
in 23.9-28.4% and subarachnoid haemorrhage in 2.9-
4.4% [10,20]. One study reported that 36% of patients
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had an embolic one [10]. Another study showed that
64% of patients with ischaemic stroke had a territorial
infarct, 19.5% a small deep infarct and 4.6% a border
zone territory infarct [17]. In this study, the distribution
of stroke with atherosclerotic and cardioembolic
mechanism did not show significant difference between
carotid versus vertebrobasilar territory involvement [17].
One study showed that vertebro-basilar territory infarc-
tions in 17% of women and 20% of men presented with
brain infarction [17]. The only study which registered
“posterior circulation strokes”, reported similar gender
distribution, with brain stem being the most common
site of stroke (59%) in the study group, followed by
cerebellum (47%) and mixed topographies (16%) [13].
Risk factors
Hypertension was the most frequent risk factor in both
ischaemic stroke (54% of patients) [10,17] as well as
spontaneous brain haemorrhage (70%-73.2% of cases)
[21,23]. Cardiac causes (54%), mainly rheumatic heart
disease (34%) were the most frequent risk factor in
young stroke [15]. In adults over 35-years old, 20% of
patients with ischaemic stroke had cardiac sources of
embolism mainly rheumatic mitral stenosis [16]. In an
aetiologic study on lacunar infarcts, hypertension, fol-
lowed by diabetes and hypercholoestrolaemia were
reported more frequently when compared with large
vessel territory infarct. However, atrial fibrillation, ipsi-
lateral carotid stenosis was more common in the latter;
smoking and history of previous TIA were not signifi-
cantly different between the two groups [11]. Summary
of all risk factors of stroke in Iran are shown in table 3.
The study on the aetiologies of posterior circulation
stroke, using Practical Iranian Classification [25],
reported atherosclerosis being the most common cause
in 50.6% of the cases, followed by uncertain causes
(25.5%), cardioembolism (12.5%), combination of athero-
sclerosis and cardioembolism (6.3%) and miscellaneous
causes (4.6%) [13].
Outcome of stroke
T h ec a s ef a t a l i t yr a t ea t2 8d a y sf o ra l lt y p eo fs t r o k e
was 19.2% in one study [10], 31.5% in another [20].
Figure 2 Details of data selection in this review.
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Study City or province Study period in years Published Language Included for assessment
Pakdaman[51] Tehran Four, 1986-1990 Persian No
Ashrafi[52] Urmia Two, 1991-1992 Persian No
Janghorbani, et al[53] Kerman Two, 1992-1994 English No
Mahmoodi[54] Yazd < two, 1993-1994 Persian No
Khandaghi[55] Tabriz One, 1994 Persian No
a
Azimian, et al[56] Hamadan One, 1994-1995 Persian No
Masoud, et al[57] Kashan One, 1996-1997 Persian No
Ashrafi, et al[58] Urmia One,1997 (1 yr) Persian No
Miabi, et al[59] Tabriz Three, 1996-1999 Persian No
Ravari, et al[60] Rafsanjan Three, 1996-1999 Persian No
Noor-Mohammadi, et al[61] Gilan Two, 1996-1998 Persian No
Harirchian, et al[62] Tehran Five, 1997-2002 English No
Andelib, et al[63] Bushehr < half a year, 1998 Persian No
Asadpour, et al[64] Sanandaj One, 1998 Persian No
Masoud[65] Tehran < a year, 1998 English No
Ebrahimi, et al[23] Kerman One 1998-1999 English No
Razaazian, et al[66] Kermanshah Two,1998-2000 Persian No
Hosseini, et al[67] Gorgan One, 1999 Persian No
EmadZadeh, et al[68] Mashhad Three, 1999-2002 Persian No
Togha, et al[22] Tehran Three, 1999-2002 English Yes
a
Sabet, et al[69] Isfahan Two, 2000-2002 English No
Oveisgharan, et al[20] Isfahan Three, 2000-2003 English Yes
Mousavi, et al[46] Isfahan Five, 2000-2004 English No
Ghandehari, et al[70] South. Khorasan Five, 2000-2005 English Duplicate
Ghandehari, et al[15] South. Khorasan Five, 2000-2005 English Yes
Nikseresht, et al[19] Shiraz Three, 2001-2003 Persian Yes
Ahangar, et al[10] Babol Two, 2001-2003 English Yes
Ahangar, et al[71] Babol Two, 2001-2003 Persian Duplicate
Ghandehari, et al[17] South. Khorasan Five, 2001-2005 English Yes
Ghandehari, et al[72] South. Khorasan Five, 2001-2005 English Duplicate
Savadi Oskoui, et al[73] Ardabil Half a year, 2002 Persian No
Savadi Oskoui, et al[74] Ardabil Half a year, 2002 Persian No
Noubahar, et al[75] Semnan One, 2002-2003 Persian No
Sarsar Shahi, et al[24] Urmia Four, 2002-2006 Persian No
a
Ghandehari, et al[12] South. Khorasan Five, 2002-2007 English Yes
b
Parniya, et al[21] Ardabil One, 2003 Persian Yes
a
Dodangeh, et al[76] Tehran < half a year 2003 Persian No
Tavassoli, et al[77] Tehran Two, 2003-2005 Persian No
b
Amini Sani, et al[78] Ardabil < two, 2004-2005 Persian No
a
Hashemilar, et al[79] Ardabil One, 2004-2005 Persian No
Ghandehari, et al[16] South. Khorasan One, 2005-2006 English Yes
a
Ghandehari, et al[11] South. Khorasan One, 2006 English Yes
a
Ghandehari, et al[14] South. Khorasan One, 2006-2007 Persian Yes
a
Ghandehari, et al[18] Mashhad One, 2007 English Yes
a
Ghandehari, et al[13] Mashhad Two, 2006-2007 English Yes
a
Iranmanesh, et al[80] Rafsanjan Not clear English No
Iranmanesh, et al[81] Rafsanjan Not clear Persian No
aThe study does not report incidence data, but designed for risk factor, mortality or prognosis analysis.
bStudy on Paediatric cases.
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Study City or
Province
Duration
of
collection
Sample
population/
number of
events
Sex Age
range
in
years
(mean
in
years)
Diagnostic
criteria/CT
or MRI
Case
ascertainment
Study
design
Event
type
Total
population
per
100,000
(95% CI)
Male Female
Ahangar
et al[10]
Babol 2001 -
2003
550,000/250 120
(48%)
130
(52%)
All
(68)
WHO/all Hospital
admission (the
only centre for
stroke
admission in
the region)
Retrospective First-ever
&
recurrent
22.7
Oveisgharan
et al[20]
Isfahan 2000 -
2003
1,700,000/
4,361
2121
(49%)
2240
(51%)
All
(68)
WHO/90% Admission in 8
hospitals in
the region
(excluded 2
military
hospitals)
Prospective First-ever
&
recurrent
a84.16
(78.46-89.86)
b94.84
(88.94-
100.74)
c100.18
(94.40-
105.96)
d103.23
(97.41-
109.05)
eGhandehari
et al[17]
Southern
Khorasan
2001 -
2005
682,000/
1,392
654
(47%)
738
(53%)
All
(65.6)
fPIC/all Hospital
admission (the
only neurology
centre in the
province)
Prospective
stroke
registry
First-ever 43.17
eGhandehari
et al[12]
Southern
Khorasan
2002 -
2007
196,000/17 10
(59%)
7
(41%)
<1 5
(5.5)
gClinical
definition/
all
Hospital
admission (the
only neurology
centre in the
province)
Prospective First-ever 1.83
eGhandehari
et al[15]
Southern
Khorasan
2000-2005 314,000/124 64
(52%)
60
(48%)
15-45
(35.7)
gClinical
definition/
all
Hospital-based
study(the only
neurology
centre in the
province)
stroke
registry
First-ever 8
CT: Computerised tomography; MRI: Magnetic Resonance Imaging; CI: 95% confidence intervals stated when available; WHO: World Health Organisation.
aIncidence rate in 2000;
bIncidence rate in 2001;
cIncidence rate in 2002;
dIncidence rate in 2003;
eOnly ischaemic strokes were included;
fPIC: Practical Iranian
Criteria classification for aetiologic and topographic diagnosis of brain infarction;
gStroke was defined as an ischaemic focal neurological deficit that persisted at
least for 24 hours.
Table 3 Frequency of risk factors in cases of stroke admitted to hospital
Study Risk factors
Event type HBP
(%)
DM
(%)
Dyslipidaemia
(%)
Cardiac diseases Smoking
(%)
CVD
(%)
FH
(%)
†Others
(%)
IHD
(%)
AF
(%)
RHD
(%)
Not
specified
(%)
- 32.8 - -
Ahangar, et al
[10]
Stroke 54 24 26 19.2 16 - 8 26 - - -
Ghandehari,
et al[17]
Stroke 53.2 13.5 8 12.2 11.4 17.7 2 15.2 22.3 10.6 †32.1
Parniya et al[21] Intracranial
Haemorrhage
36.6 5.1 2.55 - - - 6.95 9.55 - - -
Ghandehari,
et al[11]
Lacunar infarct 60.4 20 23 - 3 - 23 14 15 - ‡27
HBP:Hypertension; DM: Diabetes mellitus; CVD: Previous history of cerebrovascular disease; FH: family history of stroke; IHD: Ischaemic heart disease; AF: Atrial
fibrillation; RHD: Rheumatic heart disease. †Others risk factors reported include: low mobility, obesity and oral contraceptive. ‡ICS: Internal carotid artery stenosis
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in comparison with haemorrhagic stroke (37.6-68%)
[10,20-22]. One study showed a mortality rate of 32%
during a two year study period [10]. One hospital-based
study reported 6.1% rate of vascular dementia subse-
quent ischaemic strokes, of those, 65% had lacunar
infarct in isolation or association with large infarcts [14].
Discussion
Incidence
The available data suggest that the unadjusted incidence
of stroke in Iran is comparable to the figures from Arab
Countries [26-32], higher than sub-Saharan Africa [33],
but lower than developed countries [34], India [35], the
Caribbean & Latin America [36], and China [37]. The
apparently lower incidence may be explained by the
methodological artefact, country’s relative young popula-
tion and hospital-based case registry in the studies. The
population aged over 65 in Iran is estimated at around
5% [2], compared with 16% and 13.6% over-65 age
group in the United Kingdom and the United States of
America, respectively [38,39]. This may have an impact
on incidence reports in Iran as they are not age-
adjusted. The similarities to stroke features from Arab
countries might be related to ethnically heterogeneous
population in Iran, consists of intermixed Persian-Arab
culture, which was created since the invasion of Arabs
in the 6
th century. Genetic susceptibility for stroke and
risk factors are as a result of inter-marriage, co-evolu-
tion and free mixing between the individuals of both
ethnic backgrounds, the impact of similar geography
and environment, look-alike lifestyle and comparable
relatively young population in the Arab nations may
have played roles in the emergence of similar stroke pat-
tern between Iran and Arab countries.
There has been one attempt at a community-based
incidence study by running a stroke registry in the pro-
vince of Southern Khorasan with over 680,000 habitants
[2]. All possible stroke cases were to be referred to the
Acute Stroke Unit for evaluation prior to discharge or
admission. However, this has a significant impact on the
data collection as it may exclude patients with mild dis-
ease or those who elect not to seek medical advice lead-
ing to under-reporting and artificially low incidence.
Almost half the population seek medical advice from
the private sector [6]. This figure decreases in hospital
admissions but remains missing from the nationwide
data particularly in the Capital Tehran with numerous
private hospitals. Further studies with accepted quality
criteria and age correction are essential to represent
true incidence of the relatively young population of Iran.
None of the incidence studies fulfils criteria suggested
by Sudlow and Warlow [40] and the updated version by
Feigin [41], largely through missing a clear definition of
stroke and methodological defect, in addition to lack
of community-based case ascertainment, absence of
age-adjusted incidence and having a retrospective
design. Additionally, none of the studies was designed
specifically to represent national population. Only
well-designed studies with standard criteria can obtain
accurate data for comparable studies on stroke, a disor-
der with several different pathologies and clinical
presentations. Furthermore, the diverse society, hetero-
geneous ethnicity and marked geographical variation in
the country [1] highlight the importance of conducting
large studies, particularly in more populous parts in the
north and the capital, to up-grade the current data to
national figures. Retrospective collection of information
is more liable to cause uncertainty and blurring of clini-
cal differentiation between transient ischaemic attack
and stroke; using a coding system is unreliable and
vulnerable to diagnostic and administrative errors.
Since the general health care is divided between the
private sector and general hospitals, the maintenance of
contact, referral and follow up systems are lacking.
There is no regular system of primary health care,
neither is there regular contact with an organized nur-
sing system to fulfil the sufficient criteria for adequate
case ascertainment. Moreover, many patients with stroke
in developing countries probably consult a private doc-
tor before seeking hospital [42]. Repeatedly, a substantial
minority presented to hospital are not admitted, high-
lighting the importance of the need for an expansion of
case ascertainment to a comprehensive out-of-hospital
case-registry system. Such a system should include gen-
eral practitioners, private neurology sectors, private
neuro-imaging centres and other potential sources for
identifying stroke events, risk factors and outcomes.
Documentation and record keeping is vital; so is more
publication in internationally readable and accessible
locations. By taking these measures, the current knowl-
edge gap on stroke burden can be tackled in the
country.
Stroke patterns and risk factors
Likewise in developed countries, ischaemic stroke repre-
sents the majority of stroke subtypes, followed by pri-
mary intracranial haemorrhage and subarachnoid
haemorrhage [10,20,34]. In regards to risk factors of
ischaemic stroke, high blood pressure is the commonest
risk factor, as expected, followed by cardiac causes,
smoking and diabetes, respectively [10,17]. A survey of
risk factors of non-communicable diseases representing
Iranian adult population showed the prevalence of
hypertension and the rate of self-awareness is unaccep-
tably high, with 25% of population aged 25-64 years
being hypertensive and an additional 46% being pre-
hypertensive [43]. The study showed that only 34% of
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pressure and 25% were taking anti-hypertensive medica-
tions [43]. The findings place the prevalence of hyper-
tension, obesity and overweight in Iran as high as those
in the United States, with Iranian women, in contrast
with men, being more obese than their American coun-
terpartners [44]. The highly prevalent risk factors pat-
tern is similar to the other Arab countries neighbouring
the Persian Gulf [45]. Unlike developed countries, rheu-
matic heart disease seems to be the most common
cause of cardiac sources of embolism and many from
this group are not adequately managed for secondary
prevention of cardio-embolic stroke [16,17]. Otherwise
stroke risk factors are similar to the developing
countries.
A risk factor analysis studyc o m p a r i n gt h ea n t e r i o r
and posterior circulation strokes showed that hyperten-
sion was a major risk factor for posterior circulation
stroke, followed by smoking. Hyperlipidaemia, however,
was equally increased in both anterior and posterior cir-
culation strokes [46]. Although this study was not
designed for epidemiological evaluation, its investigation
showed some difference in comparison with the Cana-
dian study [47]. Diabetes mellitus (DM) was related to
an increased odds of posterior circulation ischemic
stroke in the latter, compared with no higher prevalence
of stroke associated with DM between anterior and pos-
terior circulation strokes in Iran [46,47].
The Practical Iranian Criteria (PIC), which was
designed for risk factor analysis and used for the largest
epidemiological study of stroke pattern, was found reli-
able and useful in clinical practice [25]. It may see-
mingly be beneficial to standardize the criteria
nationally, but lack of international recognition would
limit the national studies for worldwide comparisons.
Moreover, the PIC classification categorizes large artery
atherosclerosis and microangiopathy as atherosclerotic
mechanism, which results in an increased report of this
subtype [17]. New measures and standardised risk factor
analysis should also be included due to the substitution
of modern life-style accompanied with higher health
hazards, as well as increased global and local life-expec-
tancy urges prevention programmes.
Case fatality
T h eh o s p i t a l - b a s e d2 8 - d a yc a s ef a t a l i t yr a t ei nI r a ni s
reported at 19.2% [10] and 31.5% [20]. The former had
studied predominantly rural population near the Cas-
pian Sea with reputation to eat seafood and have healthy
diet, whereas the latter consists of over 94% urban
population in the Centre of Iran. Interestingly, the inci-
dence of stroke in the rural area at North is almost
halved compared with the other urban study [20]. It
may be concluded that lifestyle habits or local genetic
population may explain the difference in incidence and
case fatality between the two. Since there is no study
designed to compare urban and rural data, the main
reasons remain unclear and further studies are needed.
The case fatality of 31.5%, which was reported in one
study, is comparable to the figures in Sub-Saharan
Africa (30%) [33], China (27.2% for men & 32.9% for
women) [37], Latin America&t h eC a r i b b e a n( 1 9 . 3t o
26.2%) [36] and India (24.5% for urban and 37.1% for
rural population) [35]. Although the case fatality is
higher than Japan (17%), the figure is similar to the
average of 22.9% reported from 13 countries from var-
ious parts of the world [34]. However, the relevance of
the death registration system in Iran is highly subopti-
mal and the reported cause of stroke death could be up
to 15% higher than the current report [48].
Conclusion
Data on the epidemiology of stroke, its pattern and risk
factors from Iran is scarce. However, there are numer-
ous case series, mostly well-designed for the local com-
munity, reported in the literature highlighting relatively
low incidence of stroke. This may reflect a similarity
towards the neighbouring Arab nations, and a contrast
with the West. It may however, support the lack in
nationwide reliable data on the epidemiology of stroke
and its risk factors, frequently seen in developing coun-
tries. Without an intervention, an increase in stroke bur-
den is expected, as a result of ageing, population growth
and “health transition” [49,50]. To enable better health-
care planning in Iran, there is therefore, a clear necessity
for well-designed population-based comprehensive stu-
dies, updated and fulfilling published quality criteria,
along with public education and awareness to fighting
this disabling condition in this part of the world.
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